Get the Stockscreener App
2.89
0.35%
0.01
After Hours:
2.89
Compugen Ltd stock is traded at $2.89, with a volume of 671.46K.
It is up +0.35% in the last 24 hours and up +29.02% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
See More
Previous Close:
$2.88
Open:
$2.87
24h Volume:
671.46K
Relative Volume:
1.71
Market Cap:
$273.26M
Revenue:
$72.76M
Net Income/Loss:
$35.34M
P/E Ratio:
7.8256
EPS:
0.3693
Net Cash Flow:
$-62.91M
1W Performance:
+26.20%
1M Performance:
+29.02%
6M Performance:
+40.29%
1Y Performance:
+109.42%
1-Day Range:
$2.72
$2.94
1-Week Range:
$2.28
$2.94
52-Week Range:
$1.23
$2.94
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.89 | 272.32M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-07-26 | Initiated | Lake Street | Buy |
| Jan-07-26 | Initiated | H.C. Wainwright | Buy |
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
CGEN SEC FilingsCompugen 10-K, 10-Q, 8-K Forms - Stock Titan
Compugen Q1 2025 Earnings Preview - MSN
Ophir Eran (CGEN) files to sell 5,000 Ordinary shares under option plan - Stock Titan
CGEN (Nasdaq) Rule 144: 2,000-option shares to be sold; prior 26,375 sale - Stock Titan
Compugen (NASDAQ: CGEN) SVP exercises options, sells 3,125 shares under plan - Stock Titan
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference - Yahoo Finance
Levine Zurit sells 24,375 CGEN ordinary shares (CGEN) - Stock Titan
Aug Update: Can Compugen Ltd maintain sales growth2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
VIX Spike: Will Compugen Ltd outperform the market in YEARMarket Volume Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Compugen CEO Anat Cohen-Dayag to transition to executive chair - MSN
Eran Perry Net Worth (2026) - GuruFocus
Michelle Mahler Net Worth (2026) - GuruFocus
Savitzky Kinneret Livnat Net Worth (2026) - GuruFocus
Gilead Halevy Net Worth (2026) - GuruFocus
Insider Selling: Compugen (NASDAQ:CGEN) SVP Sells 5,375 Shares of Stock - MarketBeat
Compugen (CGEN) SVP exercises options and sells 7,875 Ordinary Shares - Stock Titan
Aug Update: Whats the analyst consensus on Compugen LtdWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Compugen Price Target Announced at $6.00/Share by Lake Street - Moomoo
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Str - GuruFocus
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Street | CGEN Stock News - GuruFocus
Compugen (NASDAQ:CGEN) Coverage Initiated by Analysts at Lake Street Capital - MarketBeat
Lake Street Initiates Compugen(CGEN.US) With Buy Rating, Announces Target Price $6 - Moomoo
Lake Street initiates coverage of Compugen (CGEN) with buy recommendation - MSN
Compugen (NASDAQ:CGEN) CEO Sells $12,431.25 in Stock - Defense World
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Compugen (CGEN) SVP exercises stock options and sells 3,500 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,625 shares in 10b5-1 trade - Stock Titan
Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
[144] COMPUGEN LTD SEC Filing - Stock Titan
Wed: Compugen’s big gene dream - גלובס
Compugen (CGEN) SVP uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Risk Check: How is Compugen Ltd managing supply chain issues2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Affiliate to sell 24,375 shares at CGEN (CGEN) — proposed 03/26/2026 - Stock Titan
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Truist Financial - MarketBeat
RSI Check: Does Compugen Ltd meet Warren Buffetts criteria2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
If You Invested $1,000 in Compugen (CGEN) - Stock Titan
Aug Highlights: Is Compugen Ltd stock forming a triangle pattern2026 Performance Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
CGEN (COMPUGEN LTD) CFO David Silberman discloses initial share and option holdings - Stock Titan
Compugen (CGEN) director discloses initial shares, RSUs and option grants - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CEO Ophir Eran details share and long-dated option holdings - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):